The PlA1/A2 polymorphism of glycoprotein IIIa as a risk factor for myocardial infarction: a meta-analysis.
<h4>Background</h4>The PlA2 polymorphism of glycoprotein IIIa (GPIIIa) has been previously identified as being associated with myocardial infarction (MI), but whether this represents a true association is entirely unclear due to differences in findings from different studies. We performe...
Guardado en:
Autores principales: | Christopher N Floyd, Agnesa Mustafa, Albert Ferro |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c661c5c120ef4d358ed17e45366f36e5 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The PlA1/A2 polymorphism of glycoprotein IIIa as a risk factor for stroke: a systematic review and meta-analysis.
por: Christopher N Floyd, et al.
Publicado: (2014) -
A young patient with acute myocardial infarction due to bonsai treated with glycoprotein IIbIIIa inhibitor
por: Ömer Doğan, et al.
Publicado: (2021) -
One-Year Outcome of Glycoprotein IIb/IIIa Inhibitor Therapy in Patients with Myocardial Infarction-Related Cardiogenic Shock
por: Krzysztof Myrda, et al.
Publicado: (2021) -
Practicability of Bivalirudin plus Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention: A Meta-Analysis
por: Senjie Li, et al.
Publicado: (2021) -
MiRNAs as biomarkers of myocardial infarction: a meta-analysis.
por: Chao Cheng, et al.
Publicado: (2014)